An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort.

Background: Typhoid fever causes nearly 110,000 deaths among 9.24 million cases globally and disproportionately affects developing countries. As a control measure in such regions, typhoid conjugate vaccines (TCVs) are recommended by the World Health Organization (WHO).